摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

中文名称
——
中文别名
——
英文名称
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol
英文别名
9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol化学式
CAS
——
化学式
C25H38O3
mdl
——
分子量
386.6
InChiKey
SSQJFGMEZBFMNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Process for the preparation of 3-substituted cannabinoid compounds
    申请人:e-Therapeutics plc
    公开号:US10450251B2
    公开(公告)日:2019-10-22
    There is described a method of preparing a compound of formula I, and optical isomers thereof; in which R1 is hydrogen or a protecting group; said method comprising oxidizing verbenone and optical isomers thereof.
    描述了一种制备式 I 化合物及其光学异构体的方法;其中 R1 为氢或保护基团;所述方法包括氧化马鞭草酮及其光学异构体。
  • USE OF CBX CANNABINOID RECEPTOR MODULATORS AS POTASSIUM CHANNEL MODULATORS
    申请人:Solvay Pharmaceuticals GmbH
    公开号:EP2012775A1
    公开(公告)日:2009-01-14
  • PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS
    申请人:Solvay Pharmaceuticals GmbH
    公开号:EP2026798A1
    公开(公告)日:2009-02-25
  • A DRUG SCREENING PLATFORM FOR RETT SYNDROME
    申请人:The Regents of the University of California
    公开号:EP2841067A2
    公开(公告)日:2015-03-04
  • Use of CBx cannabinoid receptor modulators as potassium channel modulators
    申请人:Antel Jochen
    公开号:US20070254863A1
    公开(公告)日:2007-11-01
    Methods of treating one or more medical conditions by administering to a subject in need thereof an effective amount of a CB x modulator having K ATP channel modulating properties are described herein. Also described are methods of using a CB x modulator having K ATP channel modulating properties to treat one or more medical conditions.
查看更多